Snowball logo
logo
2141_logo

CLASSYS Inc

214150 KQ
39,700.000.00  (0%)
Estimate
Beta
0.699
Growth
Revenue, YoY
13.05%
Net income, YoY
12.75%
FCF, YoY
-70.75%
Forecast
P/E (FWD)
11.4
EPS (FWD)
3,491.494
Dividends
Dividend yield
2.52%
Annual payout
1,000.00
Next ex. div date
December 29, 26
Payout
12.76%
Div.growth, 5y
75.54%
Dividend growth streak
8 y
Div.rating
About the company
Ticker
214150
ISIN
Country
South Korea
Sector (GICS)
Energy
CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that delivers micro-level laser beams fractionally to the tissue; Secret DUO, a multi-functional device that delivers high-frequency energy through needle electrodes; and Fortra, a 4 wavelengths diode laser. It also provides SCIZER and CLATUU Alpha for non-invasive subcutaneous fat reduction; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE, a combination of four handpieces used for acne suction, muscle pain relief, and other pain relief; FORSHAPE, an RF treatment system used to increase metabolism, blood circulation, and tissue recovery; and INTRASURE for lifting, wrinkle reduction, body contouring, and cellulite reduction. In addition, the company offers AQUAPURE II, which exfoliates hyper-keratinized dead skin cells; Reepot, a medical device that delivers energy to tissue; veloce, which enhances treatment results; Pento, a laser surgical device for tissue incision, destruction, and removal; and curas hybrid laser system. Further, it sells cosmetics. The company offers its products under the Classys, Cluederm, and Skederm brands. It serves distributors, clinics, hospitals, and direct end users. The company was founded in 2007 and is headquartered in Seoul, South Korea. CLASSYS Inc. is a subsidiary of BCPE Centur Investments, LP.

Frequently asked questions

What sector does CLASSYS Inc (214150) operate in?

CLASSYS Inc belongs to the Energy sector and operates in the Medical Devices industry.

What is CLASSYS Inc (214150) current stock price?

As of the latest data, CLASSYS Inc stock price is ₩39,700, with a previous close of ₩39,700.

What is CLASSYS Inc (214150) current market capitalization?

CLASSYS Inc market cap is approximately 2.59 trillion.

Does CLASSYS Inc (214150) pay dividends?

Yes. CLASSYS Inc pays annual dividends with an annualized yield of 2.52% and an estimated annual payout of ₩1,000 per share.

When is the next ex-dividend date for CLASSYS Inc (214150)?

The next ex-dividend date is scheduled for December 29, 2026.

How did CLASSYS Inc (214150) perform in its most recent earnings report?

In the last report (March 31, 2026), CLASSYS Inc posted an EPS surprise of 5.27% and a revenue surprise of -6.46%.

What is CLASSYS Inc (214150) beta (volatility) score?

CLASSYS Inc has a beta of 0.699, indicating lower volatility than the overall market.